Simple chat.
Deep intelligence.

Tnuki is the sales intelligence platform built for life sciences — the depth of an institutional-grade research team, at the speed of a chat. Purpose-built agents read 40+ scientific and regulatory data sources (PubMed, ClinicalTrials.gov, openFDA, NIH RePORTER, and more), the open web, and fresh buying signals (funding rounds, clinical readouts, FDA actions, executive hires), then hand biotech and pharma sales, BD, and market intelligence teams a built target list, the accounts heating up, and the decision-makers to meet — plus account dossiers and outbound emails drafted in your voice. Tnuki is augmented, not autonomous: a human reviews and sends every email. Free to start, no signup, no credit card.

General assistants like ChatGPT are great at language, but for life sciences sales research they’re limited to the open web and their training data — no integrated scientific databases, no real-time clinical or regulatory signals, no verified contacts, and no memory of your accounts. Tnuki is a purpose-built research engine: its agents read 40+ scientific and regulatory data sources (PubMed, ClinicalTrials.gov, openFDA, and more) alongside the public web, monitor 1,000+ sources for buying triggers, verify decision-makers, and compile account dossiers and drafted outreach — all grounded in sources you can click to verify. You get the ease of a chat with depth a general model structurally can’t reach.

Two camps, one gap. Apollo, ZoomInfo, and Clay are database-first: you build filters and workflows on top of a single generic dataset that has firmographics but not science — it can’t tell you a company’s lead asset, indication, trial phase, or latest readout. AI SDRs like 11x.ai ($5,000+/month) and Artisan are autonomous black boxes that optimize for volume on that same generic data. Tnuki is research-first, augmented, and built for life sciences: purpose-built agents read 40+ scientific and regulatory databases alongside the public web for the depth horizontal tools miss, while your team sees every search, enrichment, and draft and reviews and sends every email. You get an institutional-grade research team’s depth and AI speed without giving up control.

Yes — Tnuki is purpose-built for life sciences sales. Coverage is deepest across biotech and pharma, and it extends naturally to the ecosystem that sells into them: diagnostics, lab tools and instruments, CROs and CDMOs, and scientific software. The agents are tuned to the data and buying signals that decide deals in this market — clinical and regulatory milestones, FDA actions, grant and funding activity, publication and KOL movement — so the research reflects how life sciences actually buys, not a generic firmographic profile.

Tnuki goes well beyond a single database. Its agents read 40+ integrated scientific and regulatory data sources — PubMed, ClinicalTrials.gov, NIH RePORTER, openFDA, Semantic Scholar, and more — that horizontal tools like ZoomInfo or Apollo don't carry, alongside proprietary B2B data (1B+ professional profiles and 60M+ companies, with contacts verified across 10+ providers), the open web, news, funding databases, and 1,000+ live buying-signal sources. Everything is queried in real time, so the data is fresher and deeper than a static database, and every result links back to its source so your team can verify it.

Yes. Prospect lists are one output, but Tnuki is a deep-research engine for life sciences market intelligence too. The same purpose-built agents compile account dossiers, build market maps of a therapeutic area or modality, lay out competitive landscapes, and map the decision-makers and buying committees inside target accounts — in addition to producing a built target list, the accounts heating up, and ready-to-send outreach. It’s the depth of a research team, at the speed of a chat, whether you're building pipeline or sizing a market.

The Intelligence Brief is a recurring, AI-generated email that monitors your life sciences market and target accounts. Tnuki's agents scan news, LinkedIn posts, job postings, SEC and FDA filings, funding databases, clinical-trial registries, and 40+ scientific and regulatory sources, then send you a concise executive briefing organized into what matters most: competitive moves, deals and funding, regulatory shifts, people moves, and general market news. Think of it as a research team that never sleeps, delivering the news that matters straight to your inbox — daily, weekly, or on your preferred cadence.

Yes. Tnuki has a free tier — you can use the Tnuki chat to research accounts, build a target list, verify decision-makers, and draft outreach, plus receive daily plays at a regular cadence. No signup, no credit card required. Paid plans (with higher-volume usage and more frequent plays) will be announced separately.